Literature DB >> 1323623

Molecular epidemiology of envelope glycoprotein H of human cytomegalovirus.

S Chou1.   

Abstract

The complete envelope glycoprotein H (gH) coding sequences of 10 clinical strains of cytomegalovirus (CMV) were determined and compared with those of laboratory strains AD169 and Towne. Their translated peptide sequences segregated into two groups, exemplified by AD169 and Towne. Peptide variation was mostly group-specific and was clustered in the first 37 amino acids, including the signal sequence; in the rest of the molecule, there were scattered amino acid substitutions, usually in single residues. Compared with CMV envelope glycoprotein B, gH is more highly conserved among strains and may be expected to have limited immunologic diversity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1323623     DOI: 10.1093/infdis/166.3.604

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  27 in total

Review 1.  Human herpesvirus 6.

Authors:  D K Braun; G Dominguez; P E Pellett
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  The genes encoding the gCIII complex of human cytomegalovirus exist in highly diverse combinations in clinical isolates.

Authors:  Lucy Rasmussen; Aimee Geissler; Catherine Cowan; Amanda Chase; Mark Winters
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

3.  Errors in published sequences of human cytomegalovirus primers and probes: do we need more quality control?

Authors:  Wafa Habbal; Fawza Monem; Barbara Christine Gärtner
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

4.  Analysis of the variability of CMV strains in the RL11D domain of the RL11 multigene family.

Authors:  Karin Sekulin; Irene Görzer; Dorothea Heiss-Czedik; Elisabeth Puchhammer-Stöckl
Journal:  Virus Genes       Date:  2007-09-01       Impact factor: 2.332

5.  In Vitro Characterization of Human Cytomegalovirus-Targeting Therapeutic Monoclonal Antibodies LJP538 and LJP539.

Authors:  Hetalkumar D Patel; Pavel Nikitin; Thomas Gesner; James J Lin; David T Barkan; Claudio Ciferri; Andrea Carfi; Tahmineh Akbarnejad Yazdi; Peter Skewes-Cox; Brigitte Wiedmann; Nadine Jarousse; Weidong Zhong; Adam Feire; Christy M Hebner
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

6.  Distinct genotypic distributions of cytomegalovirus (CMV) envelope glycoprotein in bone marrow and renal transplant recipients with CMV disease.

Authors:  P C Woo; C Y Lo; S K Lo; H Siau; J S Peiris; S S Wong; W K Luk; T M Chan; W W Lim; K Y Yuen
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

7.  Strain-dependent differences in the human cytomegalovirus replication origin.

Authors:  Z Chen; S Watanabe; N Yamaguchi
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

8.  Nonradioactive PCR-enzyme-linked immunosorbent assay method for detection of human cytomegalovirus DNA.

Authors:  R D Allen; P E Pellett; J A Stewart; M Koopmans
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

9.  Strain-specific neutralization of human cytomegalovirus isolates by human sera.

Authors:  M Klein; K Schoppel; N Amvrossiadis; M Mach
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

10.  Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains.

Authors:  T A Cha; E Tom; G W Kemble; G M Duke; E S Mocarski; R R Spaete
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.